Risedronate Sodium-impurities | Pharmaffiliates

risedronate sodium

A pyridinyl bisphosphonate drug, used for the treatment or prevention of osteoporosis in men and women. Risedronate helps in inhibiting the osteoclast-mediated bone resorption and modulates bone metabolism. An aminobisphosphonate derivative of etidronic acid. Reference standards of Risedronate Sodium API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Risedronate Sodium - Impurity D
    [catalogue_number] => PA 18 41040
    [category_ids] => ,92,80,71,78,70,82,
    [chemical_name] => 
    [weight] => 137.14
    [form] => C7H7NO2
    [cas] => 501-81-5
    [pslug] => 501-81-5-risedronate-sodium-impurity-d-pa1841040
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 18 41040

Risedronate Sodium - Impurity D


  • Catalogue No.:PA 18 41040

  • CAS :

    501-81-5

  • Molecular Formula : C7H7NO2

  • Molecular Weight : 137.14